Bench-Ready Dispatch · Free tracked CourierPost NZ-wide on orders NZD $100+
Kiwi Peps — NZ research peptide supplyVerify this site
Back to Blog
COMPARISONS

CJC-1295 DAC vs No-DAC: Full Research Comparison

2 min readBy
CJC-1295 DAC vs No-DAC: Full Research Comparison — Comparisons research reference for New Zealand laboratories

One peptide, two very different pharmacokinetic profiles. This Kiwi Peps reference frames CJC-1295 DAC vs no-DAC as a research-design decision, with tables, mechanism and COA notes.

CJC-1295 DAC vs no-DAC is one of the most frequently asked comparisons in GHRH-analog research. The two forms share the same 30-residue GHRH backbone with identical substitutions (D-Ala², Gln⁸, Ala¹⁵, Leu²⁷). The only structural difference is the Drug Affinity Complex — a maleimide linker on Cys³⁰ that covalently binds serum albumin — and yet that single addition changes the pharmacokinetic profile of CJC-1295 by two orders of magnitude.

Head-to-head: CJC-1295 DAC vs no-DAC

AttributeWith DACNo-DAC (Mod GRF 1-29)
Structural differenceMaleimide DAC linker binds albumin covalentlyNo linker
Published half-life~6–8 days~30 minutes
GH release patternSustained bleedPulsatile (mimics native GHRH)
Reference dosing frequencyWeeklyMultiple pulses per day
Preferred blend pairingRarely combined with GHSR agonistsFrequently combined with ipamorelin
Reference research applicationSteady-state exposure and IGF-1 elevation curvesPulse-amplitude and native-kinetic studies

Which form fits which research question?

  • Pulsatile GH kinetics required → no-DAC (Mod GRF 1-29).
  • Sustained GHRH stimulation and steady IGF-1 exposure → DAC.
  • Multi-mechanism synergy with GHSR agonists (ipamorelin) → no-DAC pairing dominates the literature.
  • Simplified dosing schedule with fewer administration events → DAC.

Mechanism summary

Both forms activate the GHRH receptor on pituitary somatotrophs with identical affinity. The DAC linker does not change receptor engagement — it changes clearance. Covalent albumin binding shields CJC-1295 from renal filtration and enzymatic degradation, converting a ~30-minute molecule into a multi-day one.

  • Batch identifier and synthesis date traceable to the lot record
  • HPLC purity ≥98% (typically ≥99% for peptides under 30 residues)
  • LC-MS confirmed monoisotopic or average mass within ±0.5 Da of theoretical
  • Counterion identity and content (acetate or trifluoroacetate) reported
  • Bacterial endotoxin and residual solvents per the analytical method

CJC-1295 DAC vs no-DAC FAQ

What does DAC mean in CJC-1295?

DAC stands for Drug Affinity Complex — a maleimide linker on Cys³⁰ that binds covalently to a free cysteine on serum albumin, extending half-life from ~30 minutes to ~6–8 days.

Is Mod GRF 1-29 the same as CJC-1295 no-DAC?

Yes. Mod GRF 1-29 is the common research name for CJC-1295 without the DAC linker.

Which is better for pairing with ipamorelin?

No-DAC. Published research pairs Mod GRF 1-29 with ipamorelin because both are short-acting, producing a clean pulse rather than a sustained overlap.

Which is better for once-weekly reference dosing?

DAC. Its multi-day half-life is the reason it is documented at weekly intervals in published research.

Research use only. All information on this page is provided strictly for in-vitro and laboratory research reference. Nothing in this article is medical, therapeutic, dosing, or performance advice for human or veterinary use.

Related research articles